Physician profile
Samer Ajam
NPI 1467680942
$49,971.95
in general payments reported to CMS, 2019-2025
59 companies · $19K in 2025
The $19K reported for 2025 was more than what 89% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,808 · 2020: $3,847 · 2021: $1,834 · 2022: $4,277 · 2023: $6,886 · 2024: $7,840 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $9,668 · Travel and Lodging: $6,688 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,050.00 |
| Food and Beverage | $9,668.31 |
| Travel and Lodging | $6,688.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $14,151.12 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cp 200 Resting Electrocardiograph, Hillrom - Cardiac Ambulatory Monitor |
| Medtronic, INC. | $12,132.40 | 2021-2025 | Micra, Affera Mapping System, Pulseselect |
| Boston Scientific Corporation | $3,589.82 | 2019-2025 | Watchman Flx, Rhythmia Mapping System |
| Biosense Webster, INC. | $2,621.45 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Medtronic Vascular, INC. | $1,801.06 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,616.30 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,421.62 | 2019-2025 | Lifevest |
| Abbott Laboratories | $1,311.96 | 2019-2025 | Aveir, Ensite, Cardiomems |
| Janssen Pharmaceuticals, INC | $1,227.34 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,145.32 | 2019-2025 | |
| Medical Device Business Services, INC. | $1,030.48 | 2019 | |
| Amgen INC. | $869.58 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $844.91 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $654.49 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $533.38 | 2019-2023 | Farxiga |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $479.10 | 2025 | Rapiblyk |
| Pfizer INC. | $467.74 | 2019-2025 | |
| Cook Incorporated | $467.07 | 2020 | |
| Cook Medical LLC | $404.67 | 2019-2024 | Evolution |
| Kestra Medical Technology Services, INC. | $321.74 | 2022-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $295.43 | 2019 | |
| Esperion Therapeutics, INC. | $256.98 | 2020-2025 | Nexletol |
| Novo Nordisk INC | $238.07 | 2019-2025 | Wegovy |
| Lundbeck LLC | $217.15 | 2019-2021 | |
| Chiesi USA, INC. | $200.97 | 2020-2024 | Cleviprex, Kengreal |
| Lantheus Medical Imaging, INC. | $112.12 | 2019-2022 | |
| Itamar Medical INC | $102.73 | 2023 | Watchpatone |
| Cardiofocus, INC. | $89.95 | 2020-2024 | Heartlight System |
| Impulse Dynamics (USA) INC. | $83.50 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.24 | 2023-2025 | |
| Shockwave Medical, INC | $79.80 | 2020-2021 | |
| Atricure, INC. | $77.19 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Tactile Systems Technology INC | $71.45 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Kiniksa Pharmaceuticals, LTD. | $70.54 | 2021-2023 | Arcalyst |
| Scpharmaceuticals INC. | $68.20 | 2023-2024 | |
| Convatec INC. | $59.37 | 2019-2023 | |
| Cardiva Medical, INC. | $58.07 | 2025 | Ensoetm, Cardiva Vascade Mvp Vvcs 6-12f |
| Lilly USA, LLC | $56.43 | 2025 | Mounjaro, Zepbound |
| Kiniksa Pharmaceuticals International, Plc | $56.08 | 2024 | Arcalyst |
| Cardiovascular Systems INC. | $55.82 | 2019-2020 | |
| Vifor Pharma, INC. | $54.81 | 2019-2021 | |
| Medicomp INC | $53.54 | 2023 | Telepatch Cardiac Monitor |
| W. L. Gore & Associates, INC. | $52.20 | 2022 | |
| Amarin Pharma, INC. | $51.41 | 2019-2022 | |
| Heartflow, INC. | $50.42 | 2021-2024 | |
| Lexicon Pharmaceuticals, INC. | $42.98 | 2023-2024 | Inpefa |
| Elutia, INC. | $36.60 | 2022-2025 | Ecm Patch,Pouch |
| Ethicon US, LLC | $24.22 | 2025 | Stratafix, Ethicon, Dermabond Prineo |
| Alnylam Pharmaceuticals INC. | $22.27 | 2021 | |
| Glaxosmithkline, LLC. | $20.84 | 2025 | Shingrix |
| Regeneron Healthcare Solutions, INC. | $19.50 | 2019 | |
| Biotronik INC. | $19.37 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.51 | 2023 | Uptravi, Opsumit |
| Acutus Medical, INC. | $15.63 | 2020 | |
| Cvrx, INC. | $15.21 | 2024 | Barostim Neo System |
| Philips North America LLC | $14.65 | 2019 | |
| Angiodynamics, INC. | $14.54 | 2022 | |
| Terumo Medical Corporation | $13.61 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samer Ajam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.